Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective.
source https://www.sciencedaily.com/releases/2026/04/260409101106.htm
Trump admin’s coal investments assist plants with repeated violations
-
In 2023, after years of pollution, equipment failures, and health concerns,
the Cumberland Fossil Plant in Tennessee was slated to close within the
decad...
10 hours ago
No comments:
Post a Comment